London: Combining the treatment for the most deadly form of skin cancer with a common anti-rheumatic drug could provide more effective results, new research has shown. The findings showed that using “leflunomide” — an immunosuppressive drug approved for treatment of rheumatoid arthritis — in combination with another melanoma drug, selumetinib almost completely stopped the growth […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.